Inherited Risk Factors for Ovarian Cancer

April 8, 2020

In 2020 alone, the American Cancer Society estimates about 21,750 women will be diagnosed with ovarian cancer. While this is much lower than the 276,480 women estimated to be diagnosed with breast cancer in 2020, ovarian cancer is often more deadly and is not talked about as frequently. Therefore, knowing your risk for ovarian cancer and taking precautions before a diagnosis can help save your life and the lives of your family members.

Read More Categories: Ovarian Cancer, Genetic Testing

The 9 Signs of Ovarian Cancer Every Woman Needs to Know

March 4, 2020

Ovarian cancer begins when the genes that regulate cell growth mutate and allow abnormal cells to thrive. These rogue cells multiply at a rapid rate and eventually form a tumor. Left untreated, ovarian cancer can spread to other areas of your body. Ovarian cancer rates are highest in women in their early to mid-60s.

Read More Categories: Ovarian Cancer, Gynecologic Cancer

What to Expect After Completing Ovarian Cancer Treatment

January 27, 2020

Although completing ovarian cancer treatment is a significant event on your road to recovery, you may still need time to heal, physically and emotionally. It can take time to establish a regular routine and get comfortable with your new life after cancer treatment. Whether you want to reclaim the life you once knew or redefine it, keep in mind that it's essential to proceed at your own pace.

Read More Categories: Ovarian Cancer

Genetic Testing: Personalized Medicine at its Best

February 16, 2018

In 2013, the US Supreme Court ruled against one company owning the patent on genetic testing for BRCA1 and BRCA2 genes. Changes in these genes are associated with a high risk for breast cancer and ovarian cancer. The ruling cited that human genes are not eligible for patents because they are a product of nature. Since this ruling, the world of cancer genetic testing has opened up both scientifically and financially.

Prior to the Supreme Court ruling, only one commercial laboratory was able to offer testing for the BRCA1 and BRCA2 genes. Since the patent has been overturned, multiple laboratories have started to offer testing for BRCA1 and BRCA2 and from this, multigene cancer panels have emerged. Multigene cancer panels allow testing for many additional genes associated with breast cancer, ovarian cancer, colon cancer, and various other cancers.

Read More Categories: Ovarian Cancer, Breast Cancer, Cancer Screening, Genetic Testing, Colon & Rectal Cancer

1